United Kingdom

People: Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

16 Sep 2019
Change (% chg)

$-0.05 (-0.37%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Belanoff, Joseph 

Dr. Joseph K. Belanoff, M.D., is President, Chief Executive Officer, Director of Corcept Therapeutics Incorporated. Dr. Belanoff is a co-founder of our company and has served as a member of our Board and our Chief Executive Officer since Corcept’s inception in 1999, and as our President since 2014. Dr. Belanoff is an Adjunct Professor of Psychiatry at Stanford University (School of Medicine), where he has held positions in the Department of Psychiatry and Behavioral Sciences since 1992. Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. Dr. Belanoff brings to our Board a deep knowledge of our financial activities, commercial operations and our research and development programs. He also has valuable expertise in business administration, drug discovery, clinical medicine and psychopharmacology.

Basic Compensation

Total Annual Compensation, USD 1,157,540
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 5,157,080
Fiscal Year Total, USD 6,314,620

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 217,115 3,443,440.00
Name Fiscal Year Total

James Wilson


Joseph Belanoff


Gary Robb


Sean Maduck


Andreas Grauer


George Baker

As Of  31 Dec 2018